Patent · US Expired

Factor IX/factor IXa activating antibodies and antibody derivatives

US7279161B2 · kind B2 · utility

4Cited by

4References

9Claims

0Family size

Assignee

Baxter Aktiengesellschaft · AT

Inventors

Friedrich Scheiflinger · Wien, AT
Randolf Kerschbaumer · Klosterneuburg, AT
Falko-Guenter Falkner · Orth an der Donau, AT
Friedrich Dorner · Wien, AT
Hans-Peter Schwarz · Wien, AT

Key dates

Filing date	Mar 28, 2005
Grant date	Oct 9, 2007
Priority date	—
Expiry date	Mar 28, 2025

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/505
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An antibody or antibody derivative against factor IX/activated factor IX (FIXa) which increases the procoagulant activity of FIXa.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.